These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1373706)

  • 1. Enzymatic basis of sugar structures of alpha-fetoprotein in hepatoma and hepatoblastoma cell lines: correlation with activities of alpha 1-6 fucosyltransferase and N-acetylglucosaminyltransferases III and V.
    Ohno M; Nishikawa A; Koketsu M; Taga H; Endo Y; Hada T; Higashino K; Taniguchi N
    Int J Cancer; 1992 May; 51(2):315-7. PubMed ID: 1373706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unusually high expression of N-acetylglucosaminyltransferase-IVa in human choriocarcinoma cell lines: a possible enzymatic basis of the formation of abnormal biantennary sugar chain.
    Takamatsu S; Oguri S; Minowa MT; Yoshida A; Nakamura K; Takeuchi M; Kobata A
    Cancer Res; 1999 Aug; 59(16):3949-53. PubMed ID: 10463590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-fetoprotein-producing renal cell carcinoma with increased activity of N-acetylglucosaminyl-transferase III.
    Aoyagi Y; Mori S; Naitoh A; Yanagi M; Suzuki Y; Suda T; Isokawa O; Igarashi H; Takahashi T; Isemura M; Asakura H
    Nephron; 1996; 74(2):409-14. PubMed ID: 8893165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbohydrate structures of human alpha-fetoprotein of patients with hepatocellular carcinoma: presence of fucosylated and non-fucosylated triantennary glycans.
    Aoyagi Y; Suzuki Y; Igarashi K; Saitoh A; Oguro M; Yokota T; Mori S; Suda T; Isemura M; Asakura H
    Br J Cancer; 1993 Mar; 67(3):486-92. PubMed ID: 7679920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remodeling of sugar chain structures of human interferon-gamma.
    Fukuta K; Abe R; Yokomatsu T; Kono N; Asanagi M; Omae F; Minowa MT; Takeuchi M; Makino T
    Glycobiology; 2000 Apr; 10(4):421-30. PubMed ID: 10764830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-acetylglucosaminyltransferase III and V messenger RNA levels in LEC rats during hepatocarcinogenesis.
    Miyoshi E; Nishikawa A; Ihara Y; Gu J; Sugiyama T; Hayashi N; Fusamoto H; Kamada T; Taniguchi N
    Cancer Res; 1993 Sep; 53(17):3899-902. PubMed ID: 8240532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective suppression of N-acetylglucosaminyltransferase III activity in a human hepatoblastoma cell line transfected with hepatitis B virus.
    Miyoshi E; Nishikawa A; Ihara Y; Hayashi N; Fusamoto H; Kamada T; Taniguchi N
    Cancer Res; 1994 Apr; 54(7):1854-8. PubMed ID: 8137300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum N-acetylglucosaminyltransferase III activities in hepatocellular carcinoma.
    Mori S; Aoyagi Y; Yanagi M; Suzuki Y; Asakura H
    J Gastroenterol Hepatol; 1998 Jun; 13(6):610-9. PubMed ID: 9715405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between metastasis-associated phenotypes and N-glycan structure of surface glycoproteins in human hepatocarcinoma cells.
    Guo HB; Zhang Y; Chen HL
    J Cancer Res Clin Oncol; 2001 Apr; 127(4):231-6. PubMed ID: 11315257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetylglucosaminyltransferase IVa regulates metastatic potential of mouse hepatocarcinoma cells through glycosylation of CD147.
    Fan J; Wang S; Yu S; He J; Zheng W; Zhang J
    Glycoconj J; 2012 Aug; 29(5-6):323-34. PubMed ID: 22736280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of bisecting N-acetylglucosaminyltransferase-III in human hepatocarcinoma tissues, fetal liver tissues, and hepatoma cell lines of Hep3B and HepG2.
    Song EY; Kang SK; Lee YC; Park YG; Chung TH; Kwon DH; Byun SM; Kim CH
    Cancer Invest; 2001; 19(8):799-807. PubMed ID: 11768033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of N-acetylglucosaminyltransferases III, IV and V in normal and hepatoma tissues of rats.
    Nishikawa A; Gu J; Fujii S; Taniguchi N
    Biochim Biophys Acta; 1990 Sep; 1035(3):313-8. PubMed ID: 2145037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfection of N-acetylglucosaminyltransferase III gene suppresses expression of hepatitis B virus in a human hepatoma cell line, HB611.
    Miyoshi E; Ihara Y; Hayashi N; Fusamoto H; Kamada T; Taniguchi N
    J Biol Chem; 1995 Nov; 270(47):28311-5. PubMed ID: 7499330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Acetylglucosaminyltransferase V as a possible aid for the evaluation of tumor invasiveness in patients with hepatocellular carcinoma.
    Yanagi M; Aoyagi Y; Suda T; Mita Y; Asakura H
    J Gastroenterol Hepatol; 2001 Nov; 16(11):1282-9. PubMed ID: 11903748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substrate Preference and Interplay of Fucosyltransferase 8 and N-Acetylglucosaminyltransferases.
    Tseng TH; Lin TW; Chen CY; Chen CH; Lin JL; Hsu TL; Wong CH
    J Am Chem Soc; 2017 Jul; 139(28):9431-9434. PubMed ID: 28678517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated expression of bisecting N-acetylglucosaminyltransferase-III gene in a human fetal hepatocyte cell line by hepatitis B virus.
    Shim JK; Lee YC; Chung TH; Kim CH
    J Gastroenterol Hepatol; 2004 Dec; 19(12):1374-87. PubMed ID: 15610311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acetylglucosaminyltransferase III antagonizes the effect of N-acetylglucosaminyltransferase V on alpha3beta1 integrin-mediated cell migration.
    Zhao Y; Nakagawa T; Itoh S; Inamori K; Isaji T; Kariya Y; Kondo A; Miyoshi E; Miyazaki K; Kawasaki N; Taniguchi N; Gu J
    J Biol Chem; 2006 Oct; 281(43):32122-30. PubMed ID: 16940045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-Glycosylation of laminin-332 regulates its biological functions. A novel function of the bisecting GlcNAc.
    Kariya Y; Kato R; Itoh S; Fukuda T; Shibukawa Y; Sanzen N; Sekiguchi K; Wada Y; Kawasaki N; Gu J
    J Biol Chem; 2008 Nov; 283(48):33036-45. PubMed ID: 18812317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-acetylglucosaminyltransferase III in human serum, and liver and hepatoma tissues: increased activity in liver cirrhosis and hepatoma patients.
    Ishibashi K; Nishikawa A; Hayashi N; Kasahara A; Sato N; Fujii S; Kamada T; Taniguchi N
    Clin Chim Acta; 1989 Dec; 185(3):325-32. PubMed ID: 2482796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A catalytically inactive beta 1,4-N-acetylglucosaminyltransferase III (GnT-III) behaves as a dominant negative GnT-III inhibitor.
    Ihara H; Ikeda Y; Koyota S; Endo T; Honke K; Taniguchi N
    Eur J Biochem; 2002 Jan; 269(1):193-201. PubMed ID: 11784313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.